Acadia Pharmaceuticals | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Acadia Pharmaceuticals 0 4.12M 2024-09
ALKERMES USD 0 0 2025-06
Alnylam Pharmaceuticals USD 40.25M 1.6M 2025-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Corcept Therapeutics 6M 6M 2024-06
Cytokinetics USD 24.26M 1.32M 2025-06
Eisai 916M 174M 2025-06
Eli Lilly USD 249M 5.3M 2025-06
Incyte USD 594K 66K 2025-06
J&J USD 128M 9M 2025-03
Moderna USD 1000K 0 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Pfizer USD 654M 0 2025-06
Prothena 0 0 2024-06
PTC Therapeutics USD 30.36M 4.03M 2025-06
Sarepta Therapeutics USD 5.23M 725K 2025-06
Ultragenyx Pharmaceutical 14.04M 1.48M 2025-06
Vertex Pharmaceuticals USD 3.7M 900K 2025-06


Acadia Pharmaceuticals Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.